Both in Pharmaceuticals
Heron Therapeutics vs Rein Therapeutics
Over the past year HRTX returned −74.0% and RNTX returned −45.9%; their daily moves had a correlation of 0.12.
HRTX −74.0% RNTX −45.9%Growth of $1, one year, split-adjusted
| Metric | HRTX | RNTX |
|---|---|---|
| Price | $0.3089 | $0.7147 |
| Market cap | $58.6M | $61.7M |
| Today | +2.45% | +1.49% |
| 1 month | +0.9% | −9.5% |
| 6 months | −74.0% | −43.9% |
| Year to date | −76.2% | −38.4% |
| 1 year | −73.8% | −47.1% |
| Revenue growth (YoY) | +1.3% | — |
| Gross margin | 69.3% | — |
| Net margin | −14.6% | — |
| P/E (TTM) | — | — |
| Price / sales | 0.4× | — |
| Net cash | -$100.0M | $40.6M |
| Dividend yield | — | — |
| Volatility (60d) | 115.0% | 97.0% |
| Short % of float | 25.7% | 2.6% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).